You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS PRESENTED AT THE 44TH ANNUAL CANCER SYMPOSIUM OF THE SOCIETY OF SURGICAL ONCOLOGY, ORLANDO, FLA, March 24-27, 1991-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intraoperative Gamma Detection Probe With Presurgical Antibody Imaging in Colon Cancer

Joseph A. Kuhn, MD; Raffael M. Corbisiero, MD; Robert R. Buras, MD; Robert G. Carroll, MD; Lawrence D. Wagman, MD; Latresia A. Wilson, PhD; Dave Yamauchi, MD; Merle M. Smith, RN; Russell Kondo; J. David Beatty, MD

Arch Surg. 1991;126(11):1398-1403.


Abstract

• In this study, presurgical gamma camera imaging and an intraoperative gamma detection probe were used in 12 consecutive patients 6 to 22 days after infusion with indium 111–labeled anticarcinoembryonic antigen monoclonal antibody (111In-MoAb). In three of 11 patients who underwent laparotomy, clinical management was affected by the probe findings: localization of occult retroperitoneal disease, identification of an occult cecal lesion, and localization of residual disease at a site of local recurrence. Of all intra-abdominal lesions seen using any method, the probe identified 18 (86%) of 21, compared with 14 (67%) of 21 with the111In-MoAb scan, 10 (48%) of 21 by computed tomographic scan, and 16 (76%) of 21 after surgical exploration. Uptake of111In-MoAb in the portal (n=3) and mediastinal (n=3) lymph nodes was not associated with histologic findings of malignant neoplasms. For all pathologically confirmed extrahepatic and nonportal sites of cancer, the probe localized nine of nine, compared with five of nine by111In-MoAb scan, two of nine by computed tomographic scan, and six of nine by surgical exploration. Important clinical uses of the intraoperative probe included occult lesion identification, localization of areas with111In uptake shown with MoAb scanning, and verification of complete resection of areas with111In-MoAb uptake.

(Arch Surg. 1991;126:1398-1403)



Author Affiliations

From the Departments of Surgery (Drs Kuhn, Corbisiero, Buras, Wagman, and Beatty and Ms Smith), Radiation Research (Dr Wilson), Radiology (Dr Yamauchi), and Biostatistics (Mr Kondo), City of Hope National Medical Center, Duarte, Calif, and Carewise Medical Products Inc, Morgan Hill, Calif (Dr Carroll). Dr Beatty is now with the National Cancer Institute of Canada, Toronto, Ontario.


Footnotes

Accepted for publication July 20, 1991.

Presented at the 44th Annual Cancer Symposium of the Society of Surgical Oncology, Orlando, Fla, March 27, 1991.

Reprint requests to City of Hope National Medical Center, 1500 E Duarte Rd, Duarte, CA 91010 (Dr Beatty).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.